We compared the effect n-3
polyunsaturated fatty acids (PUFAs) with direct
renin inhibition on electrophysiological remodeling in
angiotensin II-induced cardiac injury. We treated double-transgenic rats expressing the human
renin and
angiotensinogen genes (dTGRs) from week 4 to 7 with
n-3 PUFA ethyl-
esters (
Omacor; 25-g/kg diet) or a
direct renin inhibitor (
aliskiren; 3 mg/kg per day). Sprague-Dawley rats were controls. We performed electrocardiographic, magnetocardiographic, and programmed electrical stimulation. Dietary n-3 PUFAs increased the cardiac content of eicosapentaenoic and
docosahexaenoic acid. At week 7, mortality in dTGRs was 31%, whereas none of the
n-3 PUFA- or
aliskiren-treated dTGRs died. Systolic blood pressure was modestly reduced in
n-3 PUFA-treated (180+/-3 mm Hg) compared with dTGRs (208+/-5 mm Hg).
Aliskiren-treated dTGRs and Sprague-Dawley rats were normotensive (110+/-3 and 119+/-6 mm Hg, respectively). Both
n-3 PUFA-treated and untreated dTGRs showed
cardiac hypertrophy and increased
atrial natriuretic peptide levels. Prolonged QRS and QT(c) intervals and increased T-wave dispersion in dTGRs were reduced by n-3 PUFAs or
aliskiren. Both treatments reduced
arrhythmia induction from 75% in dTGRs to 17% versus 0% in Sprague-Dawley rats. Macrophage infiltration and
fibrosis were reduced by n-3 PUFAs and
aliskiren.
Connexin 43, a mediator of intermyocyte conduction, was redistributed to the lateral cell membranes in dTGRs. n-3 PUFAs and
aliskiren restored normal localization to the intercalated disks. Thus, n-3 PUFAs and
aliskiren improved
electrical remodeling,
arrhythmia induction, and
connexin 43 expression, despite a 70-mm Hg difference in blood pressure and the development of
cardiac hypertrophy.